Syncron-E

Trends

• FDA authorizations extend clinical AI into new specialties and LLMs

Items

1. Jul 14

   FDA authorizes Autonomous Healthcare's Syncron-E

   A De Novo authorization creates a first-in-class Class II category, ventilator waveform analysis software, for AI that detects ineffective efforts and patient-ventilator asynchrony in mechanically ventilated ICU patients.